ANNOUNCEMENT {#s1}
============

The Gram-negative bacterium Escherichia coli causes serious human diseases, including bloodstream and urinary tract infections ([@B1]). The rate of antibiotic resistance in E. coli strains is rapidly rising ([@B2]), and bacteriophage therapeutics are the new frontier in combating this threat ([@B3]). Here, we describe the complete genome of a new E. coli myophage, Minorna.

Bacteriophage Minorna, against E. coli JE-1 carrying the plasmid pRA1 (RA1::Tn*5* Sq^r^), was isolated from the creek near Northgate Park in College Station, TX ([@B4]). The water sample was processed through a 0.22-μm filter. Luria broth or agar (BD) was used for growing the host and phage under aerobic conditions at 37°C, as described by Adams ([@B5]). To determine phage morphology, samples were negatively stained with 2% (wt/vol) uranyl acetate and viewed by transmission electron microscopy at the Texas A&M Microscopy and Imaging Center. Minorna genomic DNA was prepared as previously described ([@B6]) and sequenced on an Illumina MiSeq instrument with 250-bp paired-end reads using v2 500-cycle chemistry from an Illumina TruSeq Nano LT kit library. The 339,988 sequence reads from the index containing the phage genome were quality controlled using FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>) and assembled using SPAdes v3.5.0 ([@B7]) with 687-fold contig coverage after trimming using the FastX toolkit 0.0.14 (<http://hannonlab.cshl.edu>). PCR (with primers 5′-CGCGCAGCGTAGCATATAAT-3′ and 5′-GAGTTACCTGAACGTAGCGAC-3′) and Sanger sequencing confirmed that the contig was complete. Genes were called using GLIMMER v3.0 and MetaGeneAnnotator v1.0 ([@B8], [@B9]), and tRNA genes were screened with ARAGORN v2.36 ([@B10]). The gene functions were predicted with InterProScan v5.22 ([@B11]), BLAST v2.2.31 against the NCBI nr ([@B12]) and UniProt Swiss-Prot and TrEMBL databases ([@B13]), LipoP ([@B14]), and TMHMM v2.0 ([@B15]). Rho-independent termination sites were annotated using TransTermHP (<http://transterm.cbcb.umd.edu/>). All analyses were run using default parameters in the Galaxy ([@B16]) and Web Apollo ([@B17]) instances hosted by the Center for Phage Technology (<https://cpt.tamu.edu/galaxy>).

Bacteriophage Minorna is a myophage with a 43,264-bp genome. The G+C content is 51%, matching the G+C content of its host. There are 57 protein-coding genes, 26 with predicted functions, and no tRNAs, with an overall 94% coding density. Minorna was compared with other phages by progressiveMauve2.4.0 ([@B18]) and shares similarity with many Klebsiella phages, including its highest nucleotide sequence identity, at 80%, with KPV811 (GenBank accession number [KY000081](https://www.ncbi.nlm.nih.gov/nuccore/KY000081)) and its highest amino acid similarity at 84% identity to *Klebsiella* phages KpV48 ([KX237514](https://www.ncbi.nlm.nih.gov/nuccore/KX237514)), both T1-like phages. Consistent with the packaging mechanism of phage T1, headful packaging for Minorna was predicted by PhageTerm ([@B19]).

A complete lysis cassette is present at the beginning of the genome, including an endolysin with two predicted transmembrane domains (GenBank accession number [QBP07053](https://www.ncbi.nlm.nih.gov/protein/QBP07053)), a holin with one transmembrane domain ([QBP07054](https://www.ncbi.nlm.nih.gov/protein/QBP07054)), and a unimolecular spanin ([QBP07055](https://www.ncbi.nlm.nih.gov/protein/QBP07055)) similar to the T1 phage unimolecular spanin, which is associated with both bacterial membranes ([@B20], [@B21]). The morphogenesis proteins identified are also grouped together and span from the large ([QBP07058](https://www.ncbi.nlm.nih.gov/protein/QBP07058)) and small terminase subunits through tail proteins, internal core protein, major capsid protein, and portal protein ([QBP07071](https://www.ncbi.nlm.nih.gov/protein/QBP07071)). The internal core protein ([QBP07063](https://www.ncbi.nlm.nih.gov/protein/QBP07063)) is the largest protein, at 1,232 residues. Encoded proteins for replication and transcription include DNA helicase ([QBP07093](https://www.ncbi.nlm.nih.gov/protein/QBP07093)), DNA primase ([QBP07096](https://www.ncbi.nlm.nih.gov/protein/QBP07096)), DNA polymerase ([QBP07090](https://www.ncbi.nlm.nih.gov/protein/QBP07090)), and RNA polymerase ([QBP07075](https://www.ncbi.nlm.nih.gov/protein/QBP07075)). There are no identified introns or frameshifts.
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The genome sequence and associated data for phage Minorna were deposited under GenBank accession number [MK598851](https://www.ncbi.nlm.nih.gov/nuccore/MK598851), BioProject accession number [PRJNA222858](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA222858), SRA accession number [SRR8869232](https://www.ncbi.nlm.nih.gov/sra/SRR8869232), and BioSample accession number [SAMN11360441](https://www.ncbi.nlm.nih.gov/biosample/SAMN11360441).
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